In vitro IL-2 incubation induces CD69 expression and other phenotypic changes on NK subpopulations present in PBPC collections.
Baptista
M Joao
MJ
Departamento de Imuno-Hemoterapia, Instituto Português de Oncologia do Porto, Porto, Portugal.
Barbosa
Isabel L
IL
Roncon
Susana
S
Vaz
Carlos P
CP
Campilho
Fernando
F
Campos
Antonio
A
Pimentel
Pedro
P
Carvalhais
Alzira
A
D000328:Adult; D015703:Antigens, CD / Q000235:genetics*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000235:genetics*; D001781:Blood Component Removal; D016022:Case-Control Studies; D019070:Cell Lineage; D002478:Cells, Cultured; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006085:Graft Survival; D019337:Hematologic Neoplasms / Q000097:blood* / Q000628:therapy; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D016130:Immunophenotyping; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000166:cytology / Q000187:drug effects*; D037181:Lectins, C-Type; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D010641:Phenotype; D000099192:CD69 Antigens
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D007376:Interleukin-2; D037181:Lectins, C-Type; D000099192:CD69 Antigens